Pyramid Biosciences Announces Leadership Team Expansion

Pyramid Biosciences Announces Leadership Team Expansion

Pyramid Biosciences, Inc., a Boston-based, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, today announced two new appointments to the leadership team.“We are looking forward to Dr. Lestini’s leadership of our clinical programs during this important growth stage of our company.” Brian Lestini, MD, PhD, has joined the company as Chief Medical Officer, where he will oversee the advancement and expansion of the Company’s clinical pipeline. Read more >>

Share this post